Loading…
health
Hosted by Myeloma Australia · health · EN-US · 25 episodes
Welcome to MyeConversations. Myeloma Australia’s podcast series. Hosted by our expert Myeloma Support Nurses, in MyeConversations, we chat to people living with myeloma, interview experts in the field and deliver educational material on elements of this specialty area. This podcast aims to support, inform and empower those living with myeloma, their family, friends and health care professionals. If you have a question or would like to suggest a topic to be discussed please email nurses@myeloma.org.au
Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
28%
Guest openness
Selective
Sign up to generate a grounded pitch for MyeConversations by Myeloma Australia.
Signup to Generate a PitchMyeConversations by Myeloma Australia is a health podcast hosted by Myeloma Australia, with 25 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.
Myeloma Australia hosts MyeConversations by Myeloma Australia, a health show with 25 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #2
<p><b>Part 2:</b> Narelle Smith and Professor Gordon Cook continue their discussion on the use of Autologous Stem Cell Transplant (AuSCT) in treating myeloma.</p><p>This episode covers the key differences between AuSCT, allogeneic stem cell transplant, and CAR-T cell therapy, and concludes with a look at the role of maintenance therapy following an AuSCT.</p>
Episode #1
<p><b>Part 1: </b>Narelle Smith is joined by internationally renowned UK haematologist, Professor Gordon Cook, to discuss the use of Autologous Stem Cell Transplant (AuSCT) in treating myeloma.</p><p>In this episode, they explore what an AuSCT is, how the treatment process works, why it’s used, when it may not be suitable, and how best to prepare for transplant and recovery afterward.</p>
Episode #22
<p>We are joined by special international guest, Dr Adam Cohen. In this episode Dr Cohen talks about the new kids on the block, Bispecific T Cell Engagers.</p>
Episode #21
<p>EJ Furphy sits down with Sandra Russell, author of The Feeling of Cancer. This memoir gives a deeply personal and honest account of her diagnosis of myeloma and the coping mechanisms she has adopted over the years. Sandra has drawn on her professional role as a psychotherapist to explore the different feelings she had and how to make sense of her experiences. <br/><br/><br/>Disclosure:<br/>In this episode Sandra guides us through her emotional response to treatment including some complications she experienced during her stem cell transplant which might be difficult to listen to depending on your...
Episode #20
<p>In this episode Hayley Beer sits down with Donna Catamero, Nurse Practioner and Director of Myeloma Translational Research at The Mount Sinai in New York and member of the International Myeloma Foiundation Nurse Leadership Board. Hayley and Donna discuss how myeloma impacts different body systems and strategies keep people people well on and off therapy. Topics discussed include, bone, pain, kidneys, blood clots, peripheral neuropathy, GI, exercise, steriods, infections and travelling.</p>
Recent guests on MyeConversations by Myeloma Australia. Study who booked and why before you pitch.
high school science teacher, urban farmer, entrepreneur, Asset Based Lending
author of The Invisible Sale, The College of Charleston
professor in the Applied Cancer Research and Drug Discovery Division, Applied Cancer Research and Drug Discovery, Translational Genomics
Founder of Second Chance K9, Peter MacCallum Cancer Centre
Sponsor detection runs nightly. Check back soon.
Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
FAQs
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.
